Biocure Technology Inc.
Healthcare · EUR · F
Price
€0.018
Cap
€363,726
Earnings
—
30d Trend
+0.0%
171% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 33×Macro 0.99 (−1%)=33
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Biocure Technology Inc. at 33/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
—
3 MONTHS
—
12 MONTHS
-18.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Fundamentals (50) and low-risk profile are the primary strengths. I note that quality is the weakest area at 31/100 — this warrants monitoring. Historical volatility is elevated at 171%. I classify this as a speculative position — elevated volatility at 171% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.